Selected metabolic parameters and the risk for uterine fibroids

International Journal of Gynecology and Obstetrics

Volumn 102, Issue 1, 2008, Pages 50-54

  Sadlonova, Jana ^a   Kostal, Milan ^a   Smahelova, Alena ^a   Hendl, Jan ^a   Starkova, Jitka ^a   Nachtigal, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Dyslipidemia; Insulin resistance; Risk factor; Uterine fibroids

Indexed keywords

C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE BINDING PROTEIN; INSULIN;

ADULT; ARTICLE; ATHEROGENESIS; BODY MASS; CANCER RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UTERUS MYOMA;

EID: 46549085380     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.01.022     Document Type: Article

References (17)

1. Ratech H., and Stewart M.E. Uterine leiomyomas, serum cholesterol, and oral contraceptives. A preliminary study of epidemiologic differences in Los Angeles, California and Albany, New York. Diagn Gynecol Obstet 4 (1982) 21-24
2. Faerstein E., Szklo M., and Rosenshein N.B. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 153 (2001) 11-19
3. Cramer S.F., Horiszny J.A., and Leppert P. Epidemiology of uterine leiomyomas. With an etiologic hypothesis. J Reprod Med 40 (1995) 595-600
4. Mashal R.D., Fejzo M.L., Friedman A.J., Mitchner N., Nowak R.A., Rein M.S., et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 11 (1994) 1-6
5. Chung I.M., Schwartz S.M., and Murry C.E. Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development. Am J Pathol 152 (1998) 913-923
6. Moss N.S., and Benditt E.P. Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol 78 (1975) 175-190
7. Luoto R., Rutanen E.M., and Auvinen A. Fibroids and hypertension. A cross-sectional study of women undergoing hysterectomy. J Reprod Med 46 (2001) 359-364
8. Parazzini F., Chiaffarino F., Polverino G., Chiantera V., Surace M., and La Vecchia C. Uterine fibroids risk and history of selected medical conditions linked with female hormones. Eur J Epidemiol 19 (2004) 249-253
9. Marshall L.M., Spiegelman D., Barbieri R.L., Goldman M.B., Manson J.E., Colditz G.A., et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90 (1997) 967-973
10. Schwartz S.M., Marshall L.M., and Baird D.D. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect 108 Suppl 5 (2000) 821-827
11. Monzillo L.U., and Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 61 (2003) 397-412
12. Bonora E., Moghetti P., Zancanaro C., Cigolini M., Querena M., Cacciatori V., et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68 (1989) 374-378
13. Haffner S.M. Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. Horm Res 45 (1996) 233-237
14. Akinmokun A., Selby P.L., Ramaiya K., and Alberti K.G. The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet Med 9 (1992) 432-437
15. Hirst S., Phillips D.I., Vines S.K., Clark P.M., and Hales C.N. Reproducibility of the short insulin tolerance test. Diabet Med 10 (1993) 839-842
16. Young R.P., Critchley J.A., Anderson P.J., Lau M.S., Lee K.K., and Chan J.C. The short insulin tolerance test: feasibility study using venous sampling. Diabet Med 13 (1996) 429-433
17. Bosetti C., Tavani A., Negri E., Trichopoulos D., and La Vecchia C. Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. J Clin Epidemiol 54 (2001) 902-906